Page last updated: 2024-09-04

atrasentan and zibotentan

atrasentan has been researched along with zibotentan in 7 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(zibotentan)
Trials
(zibotentan)
Recent Studies (post-2010) (zibotentan)
35841108671846

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)zibotentan (IC50)
Endothelin-1 receptorHomo sapiens (human)0.021

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carducci, MA; Jimeno, A1
Lalich, M; Liu, G; McNeel, DG; Wilding, G1
Beuzeboc, P; Neuzillet, Y; Villers, A1
Espinosa, E; González, R; Merino, M; Pinto, A1
Castelo, B; Espinosa, E; Merino, M; Pinto, A; Redondo, A; Zamora, P1
Ding, Y; Feng, NH; Jiang, WY; Qiao, D; Shao, N; Wang, JL; Wang, Y; Wu, Y; Zhang, SG; Zhang, XX1
Chen, M; He, ZH; Qi, P; Song, RX; Wang, ZP; Zhang, LX1

Reviews

6 review(s) available for atrasentan and zibotentan

ArticleYear
Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Oct-15, Volume: 12, Issue:20 Pt 2

    Topics: Antineoplastic Agents; Atrasentan; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Endothelin Receptor Antagonists; Female; Humans; Male; Prostatic Neoplasms; Pyrrolidines

2006
Endothelin receptor antagonists in cancer therapy.
    Cancer investigation, 2007, Volume: 25, Issue:8

    Topics: Atrasentan; Bosentan; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Pyrimidines; Pyrrolidines; Receptors, Endothelin; Signal Transduction; Sulfonamides

2007
Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancer.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:12

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Atrasentan; Benzenesulfonates; Castration; Drug Resistance, Neoplasm; Endothelin Receptor Antagonists; Endothelins; Humans; Indoles; Lenalidomide; Male; Niacinamide; Phenylurea Compounds; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrroles; Pyrrolidines; Quinazolines; Sorafenib; Sunitinib; Thalidomide; Vascular Endothelial Growth Factor A

2011
Targeting the endothelin axis in prostate carcinoma.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:2

    Topics: Atrasentan; Bone and Bones; Carcinoma; Cell Proliferation; Clinical Trials as Topic; Endothelins; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Pyrrolidines

2012
Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer.
    International journal of cancer, 2013, Oct-01, Volume: 133, Issue:7

    Topics: Atrasentan; Disease-Free Survival; Endothelin Receptor Antagonists; Humans; Immunotherapy; Male; Orchiectomy; Proportional Hazards Models; Prostatic Neoplasms; Pyrrolidines; Tissue Extracts

2013
A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Disease-Free Survival; Docetaxel; Endothelin A Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Pyrrolidines; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome

2015

Other Studies

1 other study(ies) available for atrasentan and zibotentan

ArticleYear
[Inhibitors of the receptor A for endothelin-1].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2010, Volume: 20 Suppl 1

    Topics: Atrasentan; Endothelin A Receptor Antagonists; Humans; Male; Prostatic Neoplasms; Pyrrolidines

2010